pramipexole
Nervous system (N04)Nervous system (N04) compound in Dong Jie's portfolio. Mechanism: D2-like dopamine receptor agonist.
- Mechanism
- D2-like dopamine receptor agonist
pharma · Restless Legs Syndrome
Dong Jie
Dong Jie drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Dong Jie pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Dong Jie drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.